GENEVA, Feb. 5, 2026 /PRNewswire/ — DLG (Digital Luxury Group) today announces LuxuryIQ MCP, the first Model Context Protocol integration designed specifically for the luxury industry.
The integration gives luxury executives natural-language access to 1.4 billion data points — proprietary and public intelligence backed by two decades of DLG expertise. It connects directly to ChatGPT, Claude, Copilot, and Gemini Enterprise. The result: strategic analysis that previously took weeks, delivered in minutes — grounded in verified data, not AI guesswork.
Addressing AI Adoption Barriers
The USD 38 billion business intelligence industry has largely overlooked luxury’s specialised requirements. DLG’s recent State of AI in Luxury study, surveying over 250 luxury executives, revealed that while 71% agree AI adoption cannot be delayed, 38% cite data fragmentation as their biggest barrier, and 32% report a lack of AI-specific talent. LuxuryIQ MCP addresses these barriers by making trusted market intelligence accessible through simple conversation.
How It Works
Model Context Protocol (MCP) is an open standard allowing AI assistants to securely connect to external data sources. LuxuryIQ MCP connects DLG’s proprietary databases — social media performance, advertising activity, search demand, retail and secondary market pricing (grey market, pre-owned), and competitive intelligence — directly to the AI tools teams already use, eliminating the hallucination risk of generic AI.
LuxuryIQ MCP By DLG
The platform monitors over 185 luxury brands across watches, jewellery, fashion, and beauty in 64 markets.
“Luxury brands that move first on AI-powered intelligence will outpace competitors still waiting days for analyst reports,” says Pablo Mauron, Managing Partner at DLG. “LuxuryIQ MCP makes that advantage accessible today.”
LuxuryIQ MCP is hosted on infrastructure provided by Ogment, and is rolling out to DLG’s enterprise clients beginning Q1 2026.
About DLG
Privately held, DLG (Digital Luxury Group) combines two decades of luxury expertise with 1.4 billion proprietary data points — the foundation of its LuxuryIQ platform. The company serves 80+ enterprise clients from Geneva, Shanghai, and New York.
LUANG PRABANG, Laos, Feb. 5, 2026 /PRNewswire/ — A report by China Report ASEAN:
The list of Top 10 News Stories on 2025 Lancang-Mekong Cooperation was officially released on the evening of February 4 (Beijing time) in Luang Prabang, Laos, highlighting key achievements and milestones of cooperation among the six Lancang-Mekong countries over the past year.
The release event was attended by Yu Yunquan, Vice President of China International Communications Group (CICG), Khammone Chanthachith, Deputy Head the Propaganda and Training Commission of the Lao People’s Revolutionary Party Central Committee and Vice President of the Central Theoretical Council of the Party, Khamla Lianpadit, Deputy Secretary of the Luang Prabang Provincial Party Committee, Cai Xiangrong, Executive Deputy Director of the Publicity Department of the CPC Yunnan Provincial Committee, Zhang Sheping, Chinese Consul General in Luang Prabang, and Pongdong Paxaphacdy, Consul General of Laos in Kunming. Wang Dexin, Counselor of the Department of Asian Affairs of China’s Ministry of Foreign Affairs, addressed the event via video link.
More than 200 representatives from China and the Mekong countries, including experts and scholars, participated in the event.
In his remarks, Yu Yunquan said that in 2025, Lancang-Mekong Cooperation (LMC) made notable progress in areas including connectivity, economic development, people-to-people exchanges and security governance. The release of the annual top ten news stories, he noted, serves as a vivid record of these achievements and reflects the shared confidence of the six LMC countries in advancing cooperation and common development. He called for closer media collaboration, deeper cultural exchanges and innovative approaches to digital humanities cooperation to strengthen the Lancang-Mekong narrative.
Khammone Chanthachith said that the LMC mechanism has completed its first decade, during which it has made tangible contributions to Laos’ socio-economic development and the deepening of Laos-China friendship. Media cooperation, he added, has helped build a solid public foundation for the Laos-China community with a shared future. The release of the Top 10 News Stories on 2025 Lancang-Mekong Cooperation forms part of activities marking the 65th anniversary of diplomatic relations between Laos and China and reflects joint efforts to promote dialogue among civilizations.
Khamla Lianpadit highlighted the role of the China-Laos Railway in boosting tourism, employment and heritage conservation in Luang Prabang. He said people-to-people ties remain a solid foundation for bilateral relations and expressed hope for expanded cooperation with China in culture, industry and youth exchanges, particularly through more community-based and youth-oriented programs.
In his video address, Wang Dexin described the LMC as an exemplar and a “golden platform” for regional cooperation. Over the past decade, he said, leaders of the six countries have provided strategic guidance, advancing both bilateral and multilateral efforts to build a community with a shared future between China and the Mekong countries.
The newly released top 10 news stories offer a vivid reflection of the tangible outcomes achieved over the past year, he noted. Looking ahead, China will continue to work with Mekong countries to expand cooperation in connectivity, industrial and supply chains, artificial intelligence and green development, while promoting the continued progress of the Lancang-Mekong community with a shared future.
The event unveiled the Top 10 News Stories on 2025 Lancang-Mekong Cooperation through a video presentation. The selected stories highlight achievements in head-of-state diplomacy, ministerial meetings on foreign affairs and law enforcement security, advancements in water resources cooperation, the development of the Lancang-Mekong Innovation Corridor, growing trade between China and Mekong countries, regional railway construction, public health initiatives, youth scientific cooperation and local government exchanges.
Participants agreed that diversified platforms and innovative communication approaches are essential to telling the story of Lancang-Mekong cooperation and fostering broader dialogue, with a view to building a closer Lancang-Mekong community with a shared future.
The annual Top 10 News Stories on 2025 Lancang-Mekong Cooperation are jointly selected by CICG Center for Asia-Pacific, Yunnan International Communication Center for South and Southeast Asia, and mainstream media from Cambodia, Laos, Myanmar, Thailand and Vietnam. First launched six years ago, the initiative aims to review achievements, share experience and promote exchanges among governments, businesses, academia, agriculture and media across the Lancang-Mekong region. A tea cultural activity was also held during the release event, using tea as a medium to promote friendship and cultural exchange.
Matrix successfully demonstrates full transition flight capability
Pioneering aircraft available in 10-seat passenger and 1,500kg cargo configurations
SUZHOU, China, Feb. 5, 2026 /PRNewswire/ — AutoFlight has unveiled Matrix, the world’s first 5-ton class electric vertical take-off and landing (eVTOL) aircraft, which successfully completed a public full transition flight demonstration at the company’s low-altitude flight test facility center.
Matrix, the world’s first 5-ton class electric vertical take-off and landing (eVTOL) aircraft by AutoFlight, completes a full transition flight demonstration
During the demonstration, Matrix completed the full mode transition flight sequence, transitioning from vertical take-off through cruise flight to vertical landing. The achievement validates AutoFlight’s eVTOL technologies across complex aerodynamic systems, high-power electric propulsion, and advanced flight control systems, marking the first time a 5-ton eVTOL has achieved full transition flight.
Matrix features a 20-metre wingspan, 17.1-metre length, and 3.3-metre height, with a maximum take-off weight of 5,700kg.
The aircraft will be available in passenger and cargo variants. The passenger version offers flexible seating configurations, accommodating either 10 business-class seats or six VIP seats.
The cargo variant uses hybrid power system, supporting a maximum payload of 1,500kg, and features a large forward-opening door capable of accommodating two AKE standard air cargo containers, enhancing operational efficiency for ton-scale cargo transport.
eVTOL Industry Disruptor
AutoFlight’s CEO and Founder, Tian Yu said: “Matrix is not only a rising star in the aviation industry but also an ambitious industry disruptor. It will break the industry perception that eVTOL = short-haul, low-load, and will reshape the rules of eVTOL routes. Through economies of scale, it significantly reduces transportation costs per seat-kilometer and ton-kilometer, revolutionizing costs and embracing profitability. It covers all scenarios from urban commuting to intercity feeder routes, driving the expansion of the entire low-altitude ecosystem.”
Design and Safety Features
Matrix employs AutoFlight’s compound wing Lift and Cruise configuration with a distinctive triplane layout and six-arm structure, ensuring aerodynamic stability throughout all flight phases.
The pure electric version offers a maximum range of 250km, while the hybrid-electric variant extends range to 1,500km. The platform’s capacity positions it for diverse applications including regional travel, heavy logistics operations, and large-scale emergency response missions.
AutoFlight’s Strategic Development
Matrix represents a continuation of AutoFlight’s product strategy, following the company’s Great White Shark for industrial applications, CarryAll for autonomous logistics, and Prosperity for urban air mobility. The development program builds upon AutoFlight’s accumulated expertise in low-altitude flight technology, reliability, safety systems and airworthiness certification.
Sleeter’s background spanning defense, telecommunications, aerospace, and secure mission systems strengthens the firm’s technical leadership in wireless technology reverse engineering and patent claim analysis.
NEW YORK, Feb. 5, 2026 /PRNewswire/ — Global consulting firm J.S. Held announces today that former US Air Force Radio Frequency (RF) systems engineer Dan Sleeter has joined the Patent Analysis and Reverse Engineering group of Ocean Tomo. Sleeter brings more than 15 years of experience leading cross–functional technical teams across AI–driven RF programs, secure cloud environments, and agile delivery models supporting both national defense and commercial clients.
Summary of Dan Sleeter’s Expertise
15+ years leading cross–functional teams across AI–driven RF programs, secure cloud environments, and agile delivery models.
Deep expertise in RF systems, spectrum management, acquisition frameworks, and regulatory compliance.
Proven success delivering mission–aligned, innovation–driven, and technically rigorous solutions for DoD and commercial clients.
Specialized background in NSA secure communications, TEMPEST/EMSEC, classified RF engineering, and RFML/AI–enabled signal analysis.
Brings national–security–grade RF insight to patent analysis, reverse engineering, and complex system deconstruction.
Sleeter draws on a strong foundation of U.S. Air Force service and deep hands–on RF engineering expertise to guide clients through complex system evaluations, spectrum challenges, and intellectual property matters. His proven success managing programs for the U.S. Department of Defense (DoD) and commercial stakeholders reflects a commitment to mission alignment, technical rigor, and innovation.
“Dan brings a rare combination of national security–grade RF experience, modern AI/ML capability, and hands-on engineering depth,” said Tim Dorney PhD, Technical Lead, Patent Analysis and Reverse Engineering. “Our clients rely on us for precise, defensible interpretations of highly complex technologies, and Dan’s expertise significantly expands what our team can deliver.”
Sleeter’s expertise spans the full lifecycle of RF systems—design, testing, and maintenance of technologies enabling 4G/5G networks, Wi-Fi, radar, satellite communications, and Bluetooth. His work ensures secure, interference–free communication across telecommunications, aerospace, defense, and consumer electronics industries.
“Dan’s background in secure communications, TEMPEST/EMSEC compliance, and classified RF systems engineering directly enhances our ability to deconstruct modern wireless and sensing technologies,” added Sam Wiley, Strategic Business Intelligence Team Lead, Patent Analysis and Reverse Engineering. “His experience applying RF machine learning and automation to spectrum analysis provides a powerful advantage for our clients facing intricate IP and technical challenges.”
Sleeter has led RF/AI-enabled initiatives to characterize signal behavior, detect interference, and automate spectrum workflows across diverse software-defined radio environments. This hands-on analytical depth translates into detailed, component-level insights when evaluating patent claims, identifying infringement pathways, or mapping system architectures for Ocean Tomo clients.
“As our clients face increasingly sophisticated technologies and equally complex disputes, Dan’s combination of technical excellence and analytical discipline is exactly what our practice needs,” said James E. Malackowski, Ocean Tomo Co-founder, Head of the Intellectual Property Practice, and J.S. Held Chief Intellectual Property Officer. “We are thrilled to welcome him to the team.”
Industry Expertise
Before joining Ocean Tomo, Sleeter served as a Senior Radio Frequency Engineer with:
Huntington Ingalls Industries – the largest U.S. military shipbuilding company
Alion Science and Technology (now part of HII Mission Technologies) – a leading defense contractor supporting the DoD and intelligence community
Silver Spring Network – provider of IoT and smart grid networking technologies
He has also held RF design and testing engineering roles with:
Verizon Wireless – a global leader in 5G and fiber-optic communications
L-3 Communications (now part of L3Harris) – a major defense contractor specializing in secure communications and advanced electronic systems
Ocean Tomo’s unique understanding of intellectual property (IP) value is driven by the firm’s engagement across all matters involving intangible assets, spanning strategic planning, investments, disputes, and transactions. Litigation outcomes refine valuation methodologies, while advisory engagements are shaped by real-world insights from both the boardroom and public markets. Transaction outcomes—buying, selling, and licensing IP—validates strategic decisions and informs how IP is valued in practice. Ocean Tomo valuations used by IP owners to access capital provides insight on how financial institutions recognize IP as a bankable asset. This continuous feedback strengthens the team’s ability to deliver credible, actionable insights across all matters involving intangible assets.
About J.S. Held
J.S. Held is a global consulting firm that combines technical, scientific, financial, and strategic expertise to advise clients seeking to realize value and mitigate risk. Our professionals serve as trusted advisors to organizations facing high stakes matters demanding urgent attention, staunch integrity, proven experience, clear-cut analysis, and an understanding of both tangible and intangible assets. The firm provides a comprehensive suite of services, products, and data that enable clients to navigate complex, contentious, and often catastrophic situations.
More than 1,500 professionals serve organizations across six continents, including 84% of the Global 200 Law Firms, 75% of the Forbes Top 20 Insurance Companies (90% of the NAIC Top 50 Property & Casualty Insurers), and 71% of Fortune 100 Companies.
J.S. Held, its affiliates and subsidiaries are not certified public accounting firm(s) and do not provide audit, attest, or any other public accounting services. J.S. Held is not a law firm and does not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB or Ocean Tomo Investments, a part of J.S. Held, member FINRA/SIPC. All rights reserved.
GARLAND, Texas, Feb. 5, 2026 /PRNewswire/ — Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and advanced electric mobility solutions, today announced its participation in the 2026 Golf Course Superintendents Association of America Conference and Trade Show, taking place in Orlando, Florida from February 2 – 5, 2026. The event marks another strategic step in the Company’s ongoing push to expand fleet sales, strengthen its dealer network, and introduce its premium MVR HVAC Pro Series to institutional and commercial customers.
Massimo Group Attends 2026 GCSAA Show
At GCSAA, Massimo will showcase its second-generation MVR HVAC Pro Series, including both the Golf Version, designed for golf course operations and hospitality environments, and the Cargo Max Version, a utility-focused platform built for fleet, maintenance and commercial applications. Both models feature factory-integrated heating and air conditioning within a fully enclosed cab, addressing growing demand for year-round, all-weather electric vehicles in professional settings.
The GCSAA Conference follows three successful industry events already attended by Massimo in 2026 — AIM Expo in California, the PGA Show in Orlando, and the Mid-States Rendezvous — where the Company generated significant commercial interest across its premium HVAC product lineup. Collectively, these events have resulted in more than 100 dealer leads to date, reinforcing expanding demand for Massimo’s differentiated product offerings.
In parallel, the Company reported that January 2026 dealer-channel sales increased more than 150% year-over-year, a strong early-year indicator of accelerating dealer engagement and end-market demand.
Beyond domestic growth, Massimo has also received initial inquiries regarding exclusive distribution rights within the European Union for its MVR HVAC Pro Series. While discussions remain preliminary, the level of international interest underscores the broader global appeal of Massimo’s premium HVAC-equipped electric vehicle platforms as the Company continues to build out its dealer and distribution infrastructure.
“Each industry event we attend further validates our strategy of targeting fleet buyers and professional users with premium, climate-controlled electric vehicles,” said David Shan, CEO of Massimo Group. “The growing dealer interest, strong early-year sales momentum, and emerging international inquiries reinforce our confidence in the long-term growth potential of our HVAC Pro Series as we move into 2026 and beyond.”
Massimo’s continued focus on expanding dealer relationships, penetrating fleet markets, and introducing higher-margin premium products positions the Company to capitalize on increasing demand for reliable, all-weather electric mobility solutions across golf, commercial and utility sectors.
About Massimo Group
Massimo Group (NASDAQ: MAMO) is a U.S.-based manufacturer and distributor of powersports vehicles, utility terrain vehicles (UTVs), electric mobility solutions, and related accessories, serving customers through a nationwide dealer network.
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to Massimo Group. All statements other than statements of historical facts contained in this press release, including statements regarding Massimo Group’s future results of operations and financial position, Massimo Group’s business strategy, prospective costs, timing and likelihood of success, plans and objectives of management for future operations, future results of current and anticipated operations of Massimo Group are forward-looking statements. These include, among others, plans to accelerate dealer, fleet, and international expansion; expected demand and margins for the MVR HVAC Pro Series; preliminary EU exclusive distribution discussions; and references to long‑term growth and January 2026 dealer‑channel momentum. In some cases, forward-looking statements can be identified because they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “predict,” “project,” “target,” “potential,” “seek,” “will,” “would,” “could,” “should,” “continue,” “contemplate,” “plan,” and other words and terms of similar meaning. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to, risks relating to Massimo Group which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth economically and hire and retain key employees; costs; changes in applicable laws or regulations; the possibility that Massimo Group may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties, including those listed under “Risk Factors” in our Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Moreover, Massimo Group operates in very competitive and rapidly changing environments. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond Massimo Group’s control, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements speak only as of the date they are made. No assurance can be given regarding the forward-looking statements, and actual results may differ materially from those as indicated. Massimo Group undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source.
Unlike ISM8969, Insilico’s brain-penetrant NLRP3 pipeline already with FDA IND clearance, ISM5059 features a completely different chemical core designed for peripheral-restricted potency.
Empowered by AI, ISM5059 demonstrated robust efficacy, excellent safety profiles in preclinical studies, and low predicted human efficacious dose, with high potential in multiple indications including autoimmune and chronic cardiometabolic diseases with no obvious CNS (central nervous system) related toxicity observed in preclinical studies.
HONG KONG, Feb. 5, 2026 /PRNewswire/ — The NOD-like receptor protein 3 (NLRP3) inflammasome is a validated target for anti-inflammatory drug development. Upon activation by internal and external stimuli, NLRP3 mediates the release of proinflammatory cytokines IL-1β and IL-18, thereby driving a form of inflammatory cell death called pyroptosis. NLRP3 plays an important role in a variety of inflammatory diseases, including metabolic and cardiovascular disorders. Currently, there is a significant unmet clinical need in the treatment of systemic inflammatory diseases, highlighting the urgent demand for innovative drug options with greater efficacy and a wider safety margin.
Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the nomination of ISM5059, an AI-empowered, peripherally restricted small molecule inhibitor targeting NLRP3 as preclinical candidate compound (PCC). Guided by Pharma.AI, Insilico’s proprietary generative platform covering the whole cycle of drug discovery, ISM5059 features a novel core structure, was specifically designed to inhibit NLRP3 conformational changes and oligomerization, while maintaining exceptional safety profiles.
“Targeting NLRP3 offers tremendous potential across a pipeline-in-a-drug model. Beyond classic immune and inflammatory diseases, NLRP3 overactivation is a key driver in lifestyle-associated and metabolic disorders such as obesity, hyperlipidemia, diabetes, and cardiovascular disease.” said Feng Ren, Ph.D., Co-CEO and Chief Scientific Officer of Insilico Medicine. “More importantly, ISM5059 comes with peripheral-restricted trait and a novel chemical core structure, demonstrating how generative AI can produce highly potential molecules with desired properties and innovative structures.”
In preclinical studies, ISM5059 has demonstrated high potency and selectivity, favorable safety profiles and excellent in vivo efficacy across animal disease models, supporting broad indication potential expanding into autoimmune and inflammatory diseases, metabolic diseases, cardiovascular diseases and ophthalmology diseases. Moreover, ISM5059 is predicted to be efficacious at a low dose in humans, providing a high safety margin for future validation.
Specifically, in the in vivo peritonitis model, ISM5059 demonstrated a robust, dose-dependent inhibition of Interleukin-1β (IL-1β), a potent pro-inflammatory cytokine as a master regulator of the inflammatory response. Notably, even at the lowest tested dose of 0.3 mg/kg, IL-1β levels were nearly halved compared to the vehicle control group. This was followed by a steep, progressive reduction at higher dose levels, highlighting ISM5059’s high potency in suppressing acute inflammatory responses.
This nomination follows the recent FDA IND approval for Insilico’s other NLRP3 program, ISM8969, a potential best-in-class, brain-penetrant candidate discovered and optimized through Insilico Medicine’s Pharma.AI platform and intended for the treatment Parkinson’s disease. To accelerate the development of ISM8969, Insilico has entered into a co-development collaboration with Hygtia Therapeutics, where both parties hold 50% of the global rights, and Insilico is eligible to receive up to $66 million in upfront and milestone payments.
Harnessing state-of-the-art AI and automation technologies, Insilico has significantly improved the efficiency of preclinical drug development, setting a benchmark for AI-driven drug R&D. While traditional early-stage drug discovery typically requires an average of 4.5 years, Insilico has nominated 20 preclinical candidates from 2021 to 2024, with an average timeline—from project initiation to preclinical candidate (PCC) nomination—of just 12 to 18 months per program, with only 60 to 200 molecules synthesized and tested in each program.
About Insilico Medicine
Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend healthy longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK.
By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma.AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine. For more information, please visit www.insilico.com
Leah Goodman brings a wealth of policy and regulatory experience and is a recognized leader in Australia for advancing scientific discoveries to patient impacts.
CALGARY, AB and BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ — Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, supporting a world-first clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and treatment-resistant brain tumors, is pleased to welcome Leah Goodman to the Board of Directors.
Leah Goodman
Since late 2023, Leah Goodman has served as Chief Executive Officer of Biointelect, a leading Australian life science consultancy and CRO. She has been involved in supporting early- and late-stage biotechnology companies, as well as all levels of government and research sectors across Australia, the US, Asia, and Europe. This involvement has led to the commercialization of innovation through strategic thought and implementation which maximizes the speed of patient access. In 2025, through federal government MRFF investment, Biointelect established an incubator to support Australian SME commercialization of vaccine and infectious disease innovations.
Leah has successfully led commercial businesses across Australia, New Zealand, Japan, South Korea and various Southeast Asian markets with Sanofi, Merck KaaG and Bristol Myers Squibb.
She has a depth of experience in commercialization, business development, policy shaping, market access and regulatory affairs across a breadth of therapeutic areas including oncology and immunotherapies, as well as cell and gene therapy advanced GMP manufacturing.
Leah holds a Bachelor of Science and a Masters Degree in Commerce both from the University of NSW. She is a graduate of the Australian Institute of Company Directors (GAICD) and holds a certificate in advanced GMP manufacturing. Leah is a member of the AusBiotech NSW Leadership Council, BioNSW Commercialization committee, and was previously on the AusBiotech Cell and Gene therapy Policy and Advocacy working group.
“My excitement in joining the Providence Therapeutics Board is based on the opportunity it presents to help shape innovations that can truly transform patient lives. Throughout my career, I’ve seen how powerful scientific breakthroughs become when paired with thoughtful commercialization. Providence’s vision aligns perfectly with my motivation to enable meaningful, accessible innovation. I’m honoured to bring my global leadership experience and deep Australian insight to support the team in delivering life‑changing therapies to patients around the world.”
About Providence Therapeutics:
Founded in 2015 with headquarters in Calgary, Canada Providence Therapeutics Holdings Inc. is a clinical stage platform mRNA company with proprietary technologies and know how including: INTENT™ lipid nanoparticle delivery and expertise in mRNA design and manufacturing. Providence has multiple programs in oncology, infectious disease, and animal health.
DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ — Dubai International Financial Centre (DIFC) announced landmark annual results that underscore Dubai’s prominence as the leading global financial centre in the Middle East, Africa and South Asia (MEASA) region.
DIFC
DIFC’s 28 per cent organic year-on-year growth to 8,844 active registered companies demonstrates global industry confidence in Dubai as the region’s leading destination for finance, business and innovation. Active company registrations surged by 2,525, an increase of 39 per cent from the prior year, while recording 50,200 financial services related professionals. Combined 2025 revenues rose by 20 per cent to USD 581mn, rising from USD 484mn in 2024. Net profits increased by 28 per cent to USD 402mn from USD 315mn in 2024.
DIFC is home to the region’s largest regulated financial services system which comprises 1,052 firms, including banks, capital market institutions, insurance and reinsurance companies, brokerage firms, wealth and asset management entities. Growing at an incomparable pace, DIFC houses over 500 wealth and asset management companies.
During 2025, new financial services arrivals include Allianz Trade, Cambridge Associates, CapitaLand, China International Capital Corporation, CRDB Bank, dLocal, Howden Reinsurance, ICICI Asset Management, Manulife, National Bank of Kuwait, North Rock Capital, PIMCO, RV Capital, Silver Point Capital, Squarepoint Capital, Starwood Capital, Tourmaline, Turkiye Vakiflar Bankasi, TransAmerica Life Bermuda, Warburg Pincus and many others.
HE Essa Kazim, Governor of DIFC, commented: “DIFC’s progressive legal and regulatory framework form decisive pillars that support the phenomenal growth achieved by the Centre in 2025. Such incremental growth contributes significantly to Dubai’s economy and enhances the Emirate’s stature as a leading global financial centre, in line with national objectives and the strategic ambitions of the Dubai Economic Agenda (D33).”
As the region’s largest innovation-focused community, DIFC reached 1,677 AI and FinTech organisations in 2025. Enabled by DIFC’s Innovation Hub and Dubai AI Campus platform, start-ups have collectively raised in excess of USD 4.5bn regionally.
The Centre is now home to 1,289 family-related entities. DIFC based families have established 1,115 foundations.
Accelerating Dubai’s position as a top four global financial centre, the recently announced Zabeel District expansion adds 17.7mn sq. ft. of office, residential, hospitality, retail, cultural and education space. The development will also continue to enhance DIFC’s reputation for art, culture, dining, retail and wellness.
